News
Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit Used in Ongoing HF-REVERT Phase 2 Clinical Study. September 08, 2022 05:00 AM Eastern Daylight Time. HANOVER, Germany-- ...
KEYNOTE-756 is the first positive Phase 3 study with an immunotherapy regimen to demonstrate a statistically significant improvement in pCR rate in the neoadjuvant setting for this patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback